Literature DB >> 25232430

Single nucleotide polymorphisms of DNA mismatch repair genes MSH2 and MLH1 confer susceptibility to esophageal cancer.

Ming-Zhong Sun1, Hui-Xiang Ju1, Zhong-Wei Zhou1, Hao Jin1, Rong Zhu1.   

Abstract

Defects in DNA mismatch repair genes like MSH2 and MLH1 confer increased risk of cancers. Here, single nucleotide polymorphisms (SNPs) in MSH2 and MLH1 were investigated for their potential contribution to the risk of esophageal cancer. This study recruited 614 participants from Affiliated Yancheng Hospital, School of Medicine, Southeast University, of which 289 were patients with esophageal cancer, and the remainder was healthy individuals who served as a control group. Two SNPs, MSH2 c.2063T>G and MLH1 IVS14-19A>G, were genotyped using PCR-RFLP. Statistical analysis was performed using chi-square test and logistic regression analysis. Carriers of the MSH2 c.2063G allele were at significantly higher risk for esophageal cancer compared to individuals with the TT genotype [OR = 3.36, 95% confidence interval (CI): 1.18-11.03]. The MLH1 IVS14-19A>G allele also conferred significantly increased (1.70-fold) for esophageal cancer compared to the AA genotype (OR = 1.70, 95% CI: 1.13-5.06). Further, the variant alleles interacted such that individuals with the susceptible genotypes at both MSH2 and MLH1 had a significantly exacerbated risk for esophageal cancer (OR = 12.38, 95% CI: 3.09-63.11). In brief, SNPs in the DNA mismatch repair genes MSH2 and MLH1 increase the risk of esophageal cancer. Molecular investigations are needed to uncover the mechanism behind their interaction effect.

Entities:  

Keywords:  DNA mismatch repair; Esophageal cancer; MLH1; MSH2; single nucleotide polymorphism

Year:  2014        PMID: 25232430      PMCID: PMC4161590     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  17 in total

Review 1.  Genetic polymorphisms and esophageal cancer risk.

Authors:  Toru Hiyama; Masaharu Yoshihara; Shinji Tanaka; Kazuaki Chayama
Journal:  Int J Cancer       Date:  2007-10-15       Impact factor: 7.396

2.  [Detection of methylation of hMSH2 gene promoter region of esophageal cancer].

Authors:  Gong-yuan Zhang; Chun-xiao Ma; Qiu-liang Liu; Xiao-ping Le; Yi Ding; Qin-xian Zhang
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2005-09

Review 3.  Neoadjuvant chemotherapy or chemoradiotherapy for locally advanced esophageal cancer.

Authors:  B Mark Smithers; Iain Thomson
Journal:  Thorac Surg Clin       Date:  2013-10-13       Impact factor: 1.750

4.  Prevalence of alterations in DNA mismatch repair genes in patients with young-onset colorectal cancer.

Authors:  Paul J Limburg; William S Harmsen; Helen H Chen; Steven Gallinger; Robert W Haile; John A Baron; Graham Casey; Michael O Woods; Stephen N Thibodeau; Noralane M Lindor
Journal:  Clin Gastroenterol Hepatol       Date:  2010-11-05       Impact factor: 11.382

5.  New founding mutation in MSH2 associated with hereditary nonpolyposis colorectal cancer syndrome on the Island of Tenerife.

Authors:  Vicente Medina-Arana; Ysamar Barrios; Antonia Fernández-Peralta; Mercedes Herrera; Nancy Chinea; Nieves Lorenzo; Alejandro Jiménez; Juana Victoria Martín-López; Fernando González-Hermoso; Eduardo Salido; Juan J González-Aguilera
Journal:  Cancer Lett       Date:  2006-02-24       Impact factor: 8.679

6.  DNA mismatch repair deficiency accelerates endometrial tumorigenesis in Pten heterozygous mice.

Authors:  Hong Wang; Wayne Douglas; Marie Lia; Winfried Edelmann; Raju Kucherlapati; Katrina Podsypanina; Ramon Parsons; Lora Hedrick Ellenson
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

7.  Human MutL homolog (MLH1) function in DNA mismatch repair: a prospective screen for missense mutations in the ATPase domain.

Authors:  Aaron R Ellison; Joan Lofing; Grant A Bitter
Journal:  Nucleic Acids Res       Date:  2004-10-08       Impact factor: 16.971

8.  XPA, haplotypes, and risk of basal and squamous cell carcinoma.

Authors:  Katie L Miller; Margaret R Karagas; Peter Kraft; David J Hunter; Paul J Catalano; Steven H Byler; Heather H Nelson
Journal:  Carcinogenesis       Date:  2006-03-02       Impact factor: 4.944

Review 9.  Role of DNA mismatch repair defects in the pathogenesis of human cancer.

Authors:  Päivi Peltomäki
Journal:  J Clin Oncol       Date:  2003-03-15       Impact factor: 44.544

Review 10.  The DNA damage response and cancer therapy.

Authors:  Christopher J Lord; Alan Ashworth
Journal:  Nature       Date:  2012-01-18       Impact factor: 49.962

View more
  3 in total

1.  Single-Nucleotide Polymorphisms of the MSH2 and MLH1 Genes, Potential Molecular Markers for Susceptibility to the Development of Basal Cell Carcinoma in the Brazilian Population.

Authors:  Poliane da Silva Calixto; Otávio Sérgio Lopes; Mayara Dos Santos Maia; Sylvia Satomi Takeno Herrero; Carlos Alberto Longui; Cynthia Germoglio Farias Melo; Ivan Rodrigues de Carvalho Filho; Leonardo Ferreira Soares; Arnaldo Correia de Medeiros; Plínio Delatorre; André Salim Khayat; Rommel Rodriguez Burbano; Eleonidas Moura Lima
Journal:  Pathol Oncol Res       Date:  2017-06-30       Impact factor: 3.201

2.  Prognostic value of MLH1 promoter methylation in male patients with esophageal squamous cell carcinoma.

Authors:  Dongping Wu; Xiaoying Chen; Yan Xu; Haiyong Wang; Guangmao Yu; Luping Jiang; Qingxiao Hong; Shiwei Duan
Journal:  Oncol Lett       Date:  2017-02-22       Impact factor: 2.967

3.  Association analysis of genetic variants of adiponectin gene and risk of pancreatic cancer.

Authors:  Jian-Ping Yang; Xin Li; Feng Wang; Ming Gao; Sheng-Lei Li; Kui-Sheng Chen
Journal:  Int J Clin Exp Med       Date:  2015-05-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.